Statizoid

Health in Low income (World Bank)

156 indicators covering health for Low income (World Bank).

IndicatorLatest Year10-yr change Rank
ex - expectation of life at age x 63.67 2021 up 4.5% 10th
ndx - number of people dying between ages x and x+n 4,637 2021 down 22.5% 2nd
Cases started on MDR-TB treatment 7,337 2024 up 259.3% 9th
Raised fasting blood glucose (>=7.0 mmol/L) 6.6 2014 up 22.2% 12th
Raised fasting blood glucose (>= 7.0 mmol/L) 4.8 2014 up 23.1% 12th
Percentage of total deaths due to NCDs overall and percentage of 48.63 2019 down 19.7% 2nd
Low birth weight prevalence 14.9% 2020 down 4.5% 6th
Inactivated first-dose polio vaccine (IPV1) immunization coverage 75.0% 2025 up 316.7% 11th
Low birth weight number 3,482 2020 up 12.6% 7th
Concentrations of fine particulate matter 31.09 2023 down 8.1% 7th
New or unknown treatment history cases: Pulmonary, bacteriologically 501,851 2023 up 64.8% 7th
Number of children aged 6-59 months with anaemia 60,988 2019 up 13.9% 5th
Prevalence of anaemia in children aged 6-59 months 58.8% 2019 down 3.9% 2nd
Number of deaths attributed to non-communicable diseases, by type of 340,462 2019 up 36.7% 11th
HIV-positive TB patients on ART (antiretroviral therapy) 97.0% 2024 up 22.8% 1st
Treatment success rate for patients treated for MDR-TB 82.0% 2022 up 34.4% 1st
Treatment success rate: HIV-positive TB cases 88 2023 up 23.9% 1st
Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) 62.0% 2025 — 10th
Number of prevalent tuberculosis cases 2.10 million 2014 up 5.0% 6th
Japanese encephalitis - number of reported cases 0 2025 — 7th
Neonates protected at birth against neonatal tetanus (PAB) 81.0% 2022 up 8.0% 10th
HPV immunization coverage estimates among primary target cohort (9-14) 32.0% 2025 up 1,500.0% 6th
Tuberculosis - new and relapse cases 1.22 million 2011 up 65.9% 7th
Total number of notified TB cases 844,342 2014 up 20.4% 7th
Underweight numbers among children under 5 years of age (millions) 20,992 2024 down 1.5% 7th
Underweight prevalence among children under 5 years of age (%) 18.0% 2024 down 18.9% 2nd
Smear-positive tuberculosis treatment-success rate 87.0% 2011 up 11.5% 5th
Insufficiently active 84.92 2016 down 0.3% 4th
Yellow fever vaccine (YFV) immunization coverage among 1-year olds 48.0% 2025 up 50.0% 7th
Preterm birth rate 10.36 2020 up 1.2% 5th
Preterm birth 2.54 million 2020 up 18.7% 7th
Treatment success rate: XDR-TB cases 70 2022 up 250.0% 4th
Confirmed cases of MDR-TB 4,988 2012 up 283.4% 9th
HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) 92.0% 2014 down 5.2% 1st
Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) 23.0% 2025 up 475.0% 5th
Confirmed cases of MDR-TB started treatment for MDR-TB 70.0% 2012 — 7th